Amy Waldman
Associate Director of Neurology Gene Therapy, Children's Hospital of Philadelphia · University of Pennsylvania Health System
Credentials: · · ·
History
- Present
Leukodystrophy Center · Children's Hospital of Philadelphia
- 2007–2009
Children's Hospital of Philadelphia and Hospital of the University of Pennsylvania
- 2004–2007
Children's Hospital of Philadelphia and Hospital of the University of Pennsylvania
Research
The chemical diversity and distribution of glucosinolates and isothiocyanates among plants
Review · Phytochemistry · 2001 · 1,452 citations
Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
Neurology · 2014 · 259 citations
Journal of Neuroinflammation · 2016 · 196 citations
- EW
42 papers
41 papers
- MG
41 papers
- LB
40 papers
37 papers
37 papers
35 papers
34 papers
Grants
- 2019–2025
Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN)
National Institute of Neurological Disorders and Stroke · U54
Project lead · $650.7K · Children's Hosp of Philadelphia
- 2012–2017
Development of Visual and Neurologic Outcome Measures in Pediatric MS
National Institute of Neurological Disorders and Stroke · K23
Contact PI · $923.6K · Children's Hosp of Philadelphia
Clinical trials
- 2016–2030
Evaluation of Outcome Metrics in Alexander Disease
Principal investigator · Recruiting
Children's Hospital of Philadelphia
- 2025–2026
FIT-ATOMIC Exercise Feasibility Trial
Sub-investigator · Not yet recruiting
The Hospital for Sick Children
- 2016–2030
The Myelin Disorders Biorepository Project
Sub-investigator · Recruiting
Children's Hospital of Philadelphia